Table 1.
Sample characteristics overall and by male/female sex (N=819)
| Characteristic | Total (N = 819) | Men (N = 389) | Women (N = 430) |
|---|---|---|---|
| Age, mean ± SD, y |
58.5 ± 11.8 |
61.4 ± 10.8 |
55.9 ± 12.2 |
| Age group, No. (%) |
|
|
|
| ≤ 40 years |
59 (7) |
14 (4) |
45 (10) |
| 41 to 50 years |
127 (16) |
29 (7) |
98 (23) |
| 51 to 64 years |
377 (46) |
197 (51) |
180 (42) |
| 65 to 79 years |
232 (28) |
134 (35) |
98 (23) |
| ≥ 80 years |
21 (3) |
13 (3) |
8 (2) |
| Race, No. (%) |
|
|
|
| Black or African American |
80 (10) |
39 (10) |
41 (10) |
| American Indian/Alaska Native |
10 (1) |
6 (2) |
4 (<1) |
| Asian |
12 (1) |
2 (<1) |
10 (2) |
| Native Hawaiian/Other Pacific Islander |
2 (<1) |
1 (<1) |
1 (<1) |
| White |
705 (87) |
338 (87) |
367 (86) |
| Multiple races or other |
6 (<1) |
1 (<1) |
5 (<1) |
| Hispanic or Latino ethnicity, No. (%) |
21 (3) |
10 (3) |
11 ( 3) |
| Educational attainment, No. (%) |
|
|
|
| Less than high school |
24 (3) |
14 (4) |
10 ( 2) |
| High school graduate/GED |
100 (12) |
35 (9) |
65 (15) |
| Some college |
255 (31) |
122 (31) |
133 (31) |
| College degree |
229 (28) |
114 (29) |
115 (27) |
| Advanced degree (MA, PhD, MD) |
211 (26) |
104 (27) |
107 (25) |
| Treatment status in past month, No. (%) |
|
|
|
| None (ie, posttreatment follow-up) |
526 (64) |
290 (75) |
236 (55) |
| Undergoing treatment |
290 (36) |
98 (25) |
192 (45) |
| Radiation therapy |
29 (4) |
15 (4) |
14 (3) |
| Hormonal therapy (eg, tamoxifen, anastrozole, leuprolide) |
140 (17) |
28 (7) |
112 (26) |
| Chemotherapy (injection or oral) |
116 (14) |
46 (12) |
70 (16) |
| Immunotherapy (eg, interferon) |
9 (1) |
2 (<1) |
7 (2) |
| Other |
36 (4) |
17 (4) |
19 (4) |
| Recurrence of cancer, No. (%) |
151 (18) |
68 (17) |
83 (19) |
| Cancer spread to lymph nodes, No. (%) |
202 (25) |
68 (17) |
134 (31) |
| Cancer spread to another area, No. (%) |
134 (16) |
57 (15) |
77 (18) |
| Primary cancer diagnosis, No. (%) |
|
|
|
| Breast cancer |
252 (35) |
1 (<1) |
251 (62) |
| Colorectal |
98(13) |
57 (18) |
41 (10) |
| Gynecologic cancer |
29 (4) |
– |
29 (7) |
| Lung cancer |
56 (8) |
35 (11) |
21 (5) |
| Prostate cancer |
146 (20) |
146 (45) |
– |
| Other or Unknown | 9 (1) | 6 (2) | 3 (<1) |
Percentages may not sum to 100 because of rounding.